Crossmark

Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity

Crossref DOI link: https://doi.org/10.1186/s12944-023-01929-6

Published Online: 2023-10-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tews, Hauke Christian

Elger, Tanja

Gunawan, Stefan

Fererberger, Tanja

Sommersberger, Stefanie

Loibl, Johanna

Huss, Muriel

Liebisch, Gerhard

Müller, Martina

Kandulski, Arne

Buechler, Christa
Funding

Funding for this research was provided by:

Universitätsklinikum Regensburg
License Information

Text and Data Mining valid from 2023-10-03

Version of Record valid from 2023-10-03
More Information

Article History

Received: 1 August 2023

Accepted: 18 September 2023

First Online: 3 October 2023

Declarations

:

: The study was approved by the Ethics Committee of the University Hospital of Regensburg (Protocol No. 19–1309-101, Approval date: 20.02.2019) and all participants gave written informed consent to the study. The study was performed according to the updated guidelines of good clinical practice and updated Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below